Monographie - Gemcitabine hydrochloride

Ostatnia aktualizacja :
03/05/2024

Gemcitabine hydrochloride

Struktura chemiczna

Nazwa handlowa

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Accogem	Meksyk
Antoril	Argentyna
Axigem	Niemcy
Bendacitabin	Niemcy
Binoptos	Meksyk
Celzar	Peru
Dercin	Rumunia
Dhacibine	Malezja
Emcitab	KolumbiaKolumbia
Eriogem	Argentyna, Ekwador
Fotinex	Argentyna, Peru
Gebina	Argentyna
Gebitan	KolumbiaKolumbia
Gembio	Argentyna, Chile, Ekwador
Gemcimira	Chile, Peru
Gemcit	Portugalia
Gemcitabin	Niemcy
Gemcitac	Chile
Gemko	Turcja
Gemsibin	Turcja
Gemsol	Austria
Gemtero	Chile, Peru
Gemzar	Afryka Południowa, Australia, Austria, Belgia, Brazylia, Chile, Chorwacja, Dania, Egipt, Ekwador, Finlandia, Francja , Grecja, Hiszpania, Holandia, Iran, Irlandia, Islandia, Kanada, KolumbiaKolumbia, Luksemburg, Malezja, Maroko, Meksyk, Niemcy, Norwegia, Nowa Zelandia, Polska, Portugalia, Rumunia, Stany Zjednoczone Ameryki, Szwajcaria, Szwecja, Słowenia, Tajlandia, Tunisie, Turcja, Węgry, Wenezuela, Wielka Brytania, Włochy, Zjednoczone Emiraty Arabskie
Gentabin	KolumbiaKolumbia
Haxanit	Argentyna, Peru
Lenfotabin	Meksyk

Bibliografia : Gemcitabine hydrochloride

	Typ	Publikacja
1422	Czasopismo	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Czasopismo	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Czasopismo	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Laboratorium	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Czasopismo	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Czasopismo	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Czasopismo	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Czasopismo	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Czasopismo	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Czasopismo	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Czasopismo	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Czasopismo	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Czasopismo	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Laboratorium	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Czasopismo	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Laboratorium	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Czasopismo	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Czasopismo	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Czasopismo	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales